Medindia

X

China-Biotics to Report Fourth Quarter and Fiscal Year 2010 Financial Results on June 11

Wednesday, June 2, 2010 General News J E 4
Advertisement
- Teleconference to Be Held on Friday, June 11, 2010 at 8 a.m. EDT -

SHANGHAI, June 2 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. ("China-Biotics", the "Company") (Nasdaq: CHBT), the leading developer, manufacturer and distributor of probiotics products in China, today announced it will host a conference call at 08:00 a.m. Eastern Daylight Time on Friday, June 11, 2010, to discuss the fourth quarter and fiscal year 2010 annual financial results for the period ended March 31, 2010.

The telephone numbers for the conference call are (866) 730-5763 (U.S.) or (857) 350-1587 (International), passcode: 12247076. A live web cast of the call will also be available on the investor relations section of the Company's website http://www.chn-biotics.com . To listen to the web cast, please visit the site at least 10 minutes early to register, download and install any necessary audio software.

The replay of the web cast will be archived on the website, and investors will be able to access the recording of the conference call until midnight EDT on June 18, 2010 by calling (888) 286-8010 (U.S.) or (617) 801-6888 (International) and entering passcode: 22409856.

About China-Biotics

China-Biotics, Inc. ("China-Biotics," "the Company"), a leading manufacturer of biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements in China. Through its wholly owned subsidiary, Shanghai Shining Biotechnology Co., Ltd., the Company develops and produces its proprietary product portfolio including live microbial nutritional supplements under the "Shining" brand. Currently, the products are sold OTC through large distributors to pharmacies and supermarkets in Shanghai, Jiangsu, and Zhejiang province. In February 2010, China-Biotics began its commercial production in China's largest probiotics production facility to meet growing demand in China. For more information, please visit http://www.chn-biotics.com .

    For more information, please contact:

     Travis Cai
     Chief Financial Officer
     China-Biotics, Inc.
     Email: traviscai@chn-biotics.com

     Kevin Theiss
     Grayling
     Tel:   +1-646-284-9409
     Email: kevin.theiss@grayling.com

SOURCE China-Biotics, Inc.

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Huiheng Medical, Inc. Announces Agreement to Acqui...
S
Expecting More Medical Errors Due to Health Care R...